We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Politics > Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability
Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability
Politics

Beneath a Covid Vaccine Debacle, 30 Years of Government Culpability

Last updated: December 23, 2021 10:00 am
Editorial Board Published December 23, 2021
Share
SHARE
00emergent vaccinehub top facebookJumbo

At first, it appeared that the agency had attracted two large pharmaceutical firms — Novartis and GlaxoSmithKline — but their involvement proved temporary. The companies already had contracts with the agency to work on vaccines for influenza pandemics. It was a distinct corner of biodefense that attracted major manufacturers because they could use much of the same technology and equipment for their seasonal flu shots.

In 2012, BARDA incorporated Novartis’s flu vaccine plant in North Carolina into the new program, and GlaxoSmithKline agreed to work as a subcontractor to another winning bidder, Texas A&M University.

Within a few years, however, both pharmaceutical firms bowed out. Novartis decided to get out of the flu vaccine business, and GlaxoSmithKline stopped participating in the program with Texas A&M. The university soldiered on, and in 2020, the government enlisted it to manufacture Novavax’s Covid-19 vaccine, which is not yet authorized for use in the United States.

But it was the third winning bidder that the government relied on most heavily when the coronavirus pandemic arrived: Emergent.

‘Eyes Wide Open’

At a congressional hearing this May, the scene was eerily familiar, but this time the crisis was unparalleled in scale.

Mr. El-Hibri, facing irate questioning, declared Emergent’s manufacturing troubles “unacceptable” and pledged improvements — much as he had two decades earlier when called to answer for his company’s struggles making anthrax vaccines. Emergent was hardly flawless, he said, but it had taken on a difficult task when others had not.

“Everyone went into this with their eyes wide open,” Mr. El-Hibri testified, “that this is a facility that had never manufactured a licensed product before, that it’s a facility that, although not in perfect condition, far from it, was the facility that had the highest level of state of readiness.”

You Might Also Like

FBI investigating impersonator who hacked cellphone of Chief of Employees Susie Wiles

LEONARD GREENE: From upstart activist to political large, Charles Rangel’s loss of life marks finish of an period

Trump teases potential pardon if Sean ‘Diddy’ Combs is convicted

PBS suing Trump administration over defunding, three days after NPR filed comparable case

Elon Musk closely used medication whereas campaigning for Trump: report

TAGGED:AnthraxAstraZeneca PLCBiden, Joseph R JrBiological and Chemical WarfareBiomedical Advanced Research and Development AuthorityBotulismCoronavirus (2019-nCoV)Defense DepartmentDrugs (Pharmaceuticals)El-Hibri, FuadEmergent BioSolutions IncEpidemicsFood and Drug AdministrationGaithersburg (Md)Government Contracts and ProcurementJohnson&JohnsonModerna IncPolitics and GovernmentPublic-Private Sector CooperationSmallpoxStockpilingThe Washington MailUnited StatesVaccination and Immunization
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Mets Finish West Coast Trip As Second MLB Team to 40 Wins
Sports

Mets Finish West Coast Trip As Second MLB Team to 40 Wins

Editorial Board June 13, 2022
President Biden Arrives in Nantucket for Thanksgiving
Esai Morales is the dangerous man in ‘Mission Unattainable.’ He’s embracing it
Evaluation: Bruce Nauman’s pensive Conceptual artwork from the Seventies appears well timed once more
Damien Hirst’s Medium is the Art Market

You Might Also Like

Bronx highschool scholar Dylan detained by ICE asks decide to order his launch
Politics

Bronx highschool scholar Dylan detained by ICE asks decide to order his launch

May 30, 2025
NYC Marketing campaign Finance Board withholds .3M in matching funds from Cuomo, awards Adrienne Adams M
Politics

NYC Marketing campaign Finance Board withholds $1.3M in matching funds from Cuomo, awards Adrienne Adams $2M

May 30, 2025
Supreme Court docket lets Trump finish authorized protections for over 500,000 immigrants from 4 nations
Politics

Supreme Court docket lets Trump finish authorized protections for over 500,000 immigrants from 4 nations

May 30, 2025
Israel accepts a US proposal for a brief Gaza ceasefire and Hamas provides a cool response
Politics

Israel accepts a US proposal for a brief Gaza ceasefire and Hamas provides a cool response

May 30, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?